
Acknowledging Opportunities for Further Research in AD Management
David Rosmarin, MD, acknowledges opportunities for further research in diverse populations to continue updating AD treatment guidelines.
Episodes in this series

In the Dermatology Times Expert Perspectives series "Advancements in Atopic Dermatitis: Insights from the 2024 Masterclasses in Dermatology Conference," leading dermatologists discuss the advancements in treatments and data for atopic dermatitis (AD) with hand-foot involvement, diversity in clinical trials, and pearls from the American Academy of Dermatology's (AAD) AD treatment guidelines.
In this episode, David Rosmarin, MD, of Indiana University in Indianapolis, acknowledges opportunities for further research in diverse populations to continue updating AD treatment guidelines.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.